Last reviewed · How we verify
Pulmonary embolism
Approved treatments
- Dabigatran etexilate (DE) · Pfizer Inc.
Dabigatran etexilate (DE) as oral capsule - Xarelto · University Hospital, Montpellier
- Fragmin · Pfizer
Fragmin works by binding to and activating antithrombin, which inhibits the coagulation cascade. - Lovenox (Preservative Free) · Sanofi
Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting. - Savaysa · Daiichi Sankyo Inc
Savaysa works by blocking the action of coagulation factor X, a key protein involved in blood clotting. - Xarelto · Johnson & Johnson
Selective FXa inhibitor that decreases thrombin generation without requiring cofactors. - Pradaxa · Boehringer Ingelheim
Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development. - Sintrom
Acenocoumarol works by blocking the enzyme that helps produce clotting factors in the liver. - Activase · Roche
- Dabigatran Etexilate · Boehringer Ingelheim
Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process. - Dabigatran Etexilate · Boehringer Ingelheim
Dabigatran works by directly inhibiting the activity of thrombin, a key enzyme in the blood clotting process. - Pradaxa · Generic (originally Boehringer Ingelheim)
Direct thrombin inhibitor that blocks both free and clot-bound thrombin, providing anticoagulation without routine monitoring. - Lovenox · University of Monastir
- Activase · Medical College of Wisconsin
- Enoxaparin · Dana-Farber Cancer Institute
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary embolism patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary embolism treatment landscape brief
- Pulmonary embolism treatment updates RSS
Frequently asked questions about Pulmonary embolism
What drugs treat Pulmonary embolism?
Tracked treatments include Dabigatran etexilate (DE), Xarelto, Fragmin, Lovenox (Preservative Free), Savaysa, Pradaxa, Sintrom, Activase.
What is the treatment for Pulmonary embolism?
Standard treatment for Pulmonary embolism includes Dabigatran etexilate (DE), Xarelto, Fragmin, Lovenox (Preservative Free), Savaysa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pulmonary embolism patent cliff · Pulmonary embolism CI report
- Treatment: Dabigatran etexilate (DE) · Pfizer Inc.
- Treatment: Xarelto · University Hospital, Montpellier
- Treatment: Fragmin · Pfizer
- Treatment: Lovenox (Preservative Free) · Sanofi
- Treatment: Savaysa · Daiichi Sankyo Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing